S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
S&P 500   4,203.77 (+0.57%)
DOW   32,984.75 (+0.23%)
QQQ   349.31 (+0.38%)
AAPL   179.02 (+1.00%)
MSFT   328.30 (-0.03%)
META   270.82 (+2.30%)
GOOGL   123.18 (+0.25%)
AMZN   121.64 (+0.88%)
TSLA   202.79 (-0.56%)
NVDA   391.30 (+3.43%)
NIO   7.44 (-1.20%)
BABA   82.99 (+4.32%)
AMD   118.09 (-0.10%)
T   15.75 (+0.13%)
F   12.03 (+0.25%)
MU   68.79 (+0.87%)
CGC   0.85 (+1.80%)
GE   103.91 (+2.34%)
DIS   88.18 (+0.25%)
AMC   4.61 (+2.44%)
PFE   38.03 (+0.03%)
PYPL   62.78 (+1.27%)
NFLX   399.74 (+1.14%)
OTCMKTS:NOVSU

Novus Capital (NOVSU) Stock Forecast, Price & News

$35.75
+3.04 (+9.29%)
(As of 01/29/2021)
Compare
Today's Range
$32.21
▼
$35.81
50-Day Range
$35.75
▼
$35.75
52-Week Range
$9.90
▼
$38.77
Volume
1,400 shs
Average Volume
3,537 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlines

Receive NOVSU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Novus Capital and its competitors with MarketBeat's FREE daily newsletter.

NOVSU Stock News Headlines

May 31, 2023 | markets.businessinsider.com
LifeSci Capital Reaffirms Their Buy Rating on Eledon Pharmaceuticals (ELDN)
May 31, 2023 | americanbankingnews.com
Novus Capital (OTCMKTS:NOVSU) Trading Up 9.3%
June 1, 2023 | Edge On The Street (Ad)
AI Getting Close to Thinking Like Humans
Technology experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do.
May 22, 2023 | msn.com
Novus Aviation Capital establishes SAF One
May 21, 2023 | msn.com
Aqueduct Park: Escape The Crowds & See The Massive Roman Aqueducts Just Outside Rome
May 17, 2023 | finanznachrichten.de
Novus Acquisition and Development Corporation: Novus Releases Its First Quarter Financial Statements For 2023
May 16, 2023 | markets.businessinsider.com
Maxim Group Sticks to Their Buy Rating for Energy Vault Holdings (NRGV)
May 15, 2023 | markets.businessinsider.com
SVB Securities Sticks to Their Buy Rating for Eledon Pharmaceuticals (ELDN)
June 1, 2023 | Edge On The Street (Ad)
AI Getting Close to Thinking Like Humans
Technology experts working with neuroscientists have created the world's first Artificial Intelligence Network Operating System. AI can now process information like the human brain and understand the world the way humans do.
May 12, 2023 | markets.businessinsider.com
Eledon Pharmaceuticals (ELDN) Gets a Buy from LifeSci Capital
May 6, 2023 | marketwatch.com
Global "Rumen Protected Choline Market" Survey & Forecast | With 104+ Pages
May 5, 2023 | finance.yahoo.com
COMPREHENSIVE HEALTHCARE SYSTEMS INC. ANNOUNCES APPOINTMENT OF INTERIM CHIEF FINANCIAL OFFICER
April 10, 2023 | marketwatch.com
Philippines Petroleum Market Overview, Product Specifications, Innovative Trends and Competitive Outlook till 2027
March 15, 2023 | msn.com
What Happens If You Don't Complete Your Laser Hair Removal Sessions?
March 7, 2023 | msn.com
Technological Innovations Aid SEI Investments (SEIC), Costs Ail
February 27, 2023 | msn.com
Japan to relax border controls for passengers from China from Wednesday
February 27, 2023 | msn.com
Analysis: Some highly rated US companies take unusual funding route as rates rise
February 27, 2023 | news.yahoo.com
Ukraine's economy stabilizes after shock of war
February 23, 2023 | marketwatch.com
Global Antibody Pair Kit Market Size 2023 Business Strategies, Growth Analysis, Regional Demand, 2030 Forecast Research Report By VMReports
February 20, 2023 | insidermonkey.com
Know Labs, Inc. (ASE:KNW) Q1 2023 Earnings Call Transcript
February 20, 2023 | insidermonkey.com
Hercules Capital, Inc. (NYSE:HTGC) Q4 2022 Earnings Call Transcript
February 15, 2023 | benzinga.com
IngredientWerks announces successful completion of seed round funding
February 13, 2023 | msn.com
The Different Catholic Churches Explained (And Why There Are 24 Of Them)
February 9, 2023 | yahoo.com
NEW DEEP EARTH GEOTHERMAL POWERED CONTROLLED ENVIRONMENT AGRICULTURE PROJECT
January 30, 2023 | yahoo.com
COMPREHENSIVE HEALTHCARE SYSTEMS INC. ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED NON-BROKERED PRIVATE PLACEMENT
January 25, 2023 | reuters.com
Brazil's economy to stay weak amid doubts over Lula's spending push
January 10, 2023 | finanznachrichten.de
Novus Acquisition and Development Corporation: Why Novus Doesn't Need SAFE Banking Act To Grow Revenue
See More Headlines

NOVSU Price History

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Shell Companies
Sub-Industry
N/A
Sector
Finance
Current Symbol
OTCMKTS:NOVSU
CUSIP
N/A
CIK
N/A
Web
novuscapitalcorporation.com
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Larry M. Paulson (Age 67)
    CEO & Director
  • Mr. Vincent Donargo (Age 60)
    Chief Financial Officer

Key Competitors

View All Competitors













NOVSU Stock - Frequently Asked Questions

How have NOVSU shares performed in 2023?

Novus Capital's stock was trading at $35.75 on January 1st, 2023. Since then, NOVSU shares have increased by 0.0% and is now trading at $35.75.
View the best growth stocks for 2023 here.

What is Novus Capital's stock symbol?

Novus Capital trades on the OTCMKTS under the ticker symbol "NOVSU."

How do I buy shares of Novus Capital?

Shares of NOVSU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Novus Capital's stock price today?

One share of NOVSU stock can currently be purchased for approximately $35.75.

This page (OTCMKTS:NOVSU) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -